Roby Zomer Archives | Cannabiz

Cannabis executive salaries: who earned what in FY26

by Adam Sheldon October 15, 2026October 16, 2026

Another year of financial pressure, boardroom upheaval and regulatory scrutiny tested executives running Australia’s ASX-listed cannabis […]

Argent shares soar after CannEpil deal wipes out US$5.5m debt

by Adam Sheldon July 7, 2026July 7, 2026

News in brief: 150 applications for council CEO role; Rua sends NZ genetics to Canada; Argent completes pet business deal

by Steve Jones April 15, 2026April 15, 2026

Argent inks binding agreement to buy AusCann’s CannPal stake

by Adam Sheldon January 15, 2026January 15, 2026

Roby Zomer

Argent BioPharma secures A$11m facility to complete AusCann acquisition

by Adam Sheldon November 17, 2025February 21, 2026

Roby Zomer

Argent BioPharma inks deal to acquire AusCann assets and IP

by Martin Lane August 19, 2025August 21, 2025

Argent Biopharma and Auscann sign deal to ‘enhance drug development’

by Steve Jones April 23, 2025April 23, 2025

Roby Zomer

New name for MGC Pharma

by Martin Lane April 2, 2024July 16, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Company news: MediCann Health; MGC Pharma; Bod Science

by Martin Lane November 8, 2023April 30, 2024